For many people, surgery is the first treatment for breast cancer, but it is not always first. Sometimes doctors recommend treatment before surgery. This is called neoadjuvant therapy, which simply means treatment given before the main treatment, in this case before the operation.
Hearing that surgery will wait can feel worrying, but there are good reasons for this order. This guide explains why treatment before surgery is suggested, which treatments can be used, and how the team measures how well it is working.
What Neoadjuvant Therapy Means in Plain Words
Neoadjuvant therapy is treatment given before surgery to shrink a cancer and begin tackling it throughout the body straight away. The treatments used are the same ones that might otherwise be given after surgery. Only the order is different.
Treatment after surgery is called adjuvant therapy. Neoadjuvant and adjuvant treatments often use the same medicines and approaches, and your team chooses the order that best fits the size, type, and stage of your cancer.
You may also hear the phrase primary systemic therapy, which means the same thing. Whichever words your team uses, you can always ask them to explain the plan in plain language.
Why Doctors Suggest Treatment Before Surgery
The main reason is to shrink the cancer. A smaller cancer may make surgery easier, and shrinking may turn an operation that needed a mastectomy into one where breast conserving surgery is possible.
Starting treatment early also tackles any cancer cells elsewhere in the body without delay, and it shows the team how your cancer responds, which is valuable information for planning what comes after surgery.
Another reason is practical. Starting with medicine treatment can give you time to consider surgical choices, arrange support at home, or complete genetic testing that may shape the operation you choose.
Which Treatments Can Be Used Before Surgery
Chemotherapy is the treatment most often used before surgery. Targeted therapy may be added for HER2 positive cancers, and immunotherapy is used for some triple negative cancers, sometimes combined with chemotherapy.
Hormone therapy can be used before surgery for some hormone receptor positive cancers, particularly in older patients or when chemotherapy is not suitable. Radiation is only rarely used in this position. Your team will explain which combination fits your diagnosis.
Before treatment begins, a tiny marker clip is often placed in the cancer during a biopsy, so the surgeon can find the exact area later even if the cancer shrinks away on scans.
How the Team Measures How Well It Is Working
During neoadjuvant treatment, the team checks the cancer regularly with examinations and imaging, such as ultrasound or MRI, to see whether it is shrinking. Blood tests and your general health are monitored at each cycle as well.
After surgery, the tissue removed is examined closely. If no active cancer remains, doctors call this a complete response, which is a good sign. If some cancer remains, that information guides further treatment after surgery.
Shrinkage does not always show evenly, and scans are estimates rather than exact measures. That is why the laboratory examination of the removed tissue after surgery gives the most complete answer about response.
Surgery After Neoadjuvant Treatment
When the course of treatment ends, surgery follows, usually within a few weeks. The operation removes the area where the cancer was, and lymph nodes are checked as usual, often using the sentinel node approach.
Whether the cancer shrank a lot or a little, surgery is still an important part of the plan for most people, because it removes remaining tissue that imaging cannot fully judge. Your surgeon will plan the operation using images taken before and after treatment.
Feelings and Patience During a Longer Timeline
Treatment before surgery makes the road to the operation longer, often several months, and that wait can be emotionally hard. It can help to remember that you are not waiting without treatment. The treatment is the work happening now.
Ask your team for a clear timeline, keep a note of your questions between visits, and accept support from family, friends, or support services. If the plan needs to change because the cancer responds differently than hoped, your team will explain why and what happens next.
Many people say it helps to mark milestones, such as the halfway cycle, and to keep ordinary life going where possible with work, family time, and rest planned around treatment days.
Frequently Asked Questions
Does having treatment first mean my cancer is worse?
Not necessarily. Neoadjuvant therapy is chosen for the plan it makes possible, not only for advanced cancers. It is used for some early stage cancers too, particularly certain triple negative and HER2 positive cancers, because response to treatment guides later choices.
What if the cancer does not shrink?
If scans show the cancer is not responding, the team can change the treatment or move surgery earlier. You will be monitored throughout, and the plan is never left to drift. Not shrinking as hoped is disappointing, but there are always next steps to discuss.
Will I still need treatment after surgery?
Often, yes, though it depends on how the cancer responded and on its original features. Some people have radiation, hormone therapy, or further medicine treatment after surgery. Your team will base the plan on the pathology results from the operation.
A Note on Medical Information
The information on this website is for general educational purposes only and is not medical advice. It does not replace the advice, diagnosis, or treatment of a qualified healthcare professional. If you notice a change in your breast or have concerns about your health, please contact a healthcare professional promptly.